arrow
G

Georges Gebrael

Utah System of Higher Education
H指数:10
被引数:464

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials

种族与接受阿帕鲁他胺治疗患者生存期的关联:两项III期试验的合并分析

Cancer
IF5.1
2026-01-010
PRE
IUC24428-85 Real-world effectiveness of ipilimumab plus nivolumab in second-line in patients with metastatic clear cell renal cell carcinoma (mccRCC) based on prior receipt of PD-1/L1 inhibitors

IUC24428-85 基于既往接受PD-1/L1抑制剂治疗的患者,伊匹木单抗联合纳武利尤单抗在二线治疗转移性透明细胞肾细胞癌(mccRCC)中的真实世界有效性

2025-08-290
OA
T-cell Engagers in Prostate Cancer

T细胞结合剂在前列腺癌中的应用

2025-05-011
PRE
Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy

接受强化雄激素剥夺治疗的转移性激素敏感性前列腺癌患者生存的基因组生物标志物

2025-01-310
PRE
Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy with relugolix

使用鲁格利克间歇性雄激素剥夺疗法治疗的晚期前列腺癌患者的睾酮抑制与恢复

2024-11-080
OA
Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216

体重指数与转移性激素敏感性前列腺癌患者总生存期的相关性:SWOG-1216患者层面数据分析

2024-11-010
PRE
Impact of Synchronous versus Metachronous Metastasis on Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with First-line Immune Checkpoint Inhibitor-based Combinations
2024-09-010
OAAI
Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of the TITAN Trial
2024-07-261
PRE
Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database Consortium
2024-07-012
OAAI
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor
CANCER
IF5.1
2024-04-020
OAAI
Effect of Prior Prostate Directed Local Therapy on Response to Apalutamide in Metastatic Hormone Sensitive Prostate Cancer: A Secondary Analysis of the TITAN Study
2024-04-011
PRE